Pancreatic Cancer Research

ResearcherCapital Medical UniversityActive in the last 2 years

Haowei Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-7608-4877; OpenAlex author ID A5100867670. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 3

  1. Prognostic significance of three lymph node staging systems in pancreatic cancer with ≤ 12 and > 12 retrieved lymph nodes. Co-author DOI 10.1007/s13304-025-02075-7↗
  2. DNMT1-Induced Downregulation of CBX7 Inhibits ERK Phosphorylation and Promotes Pancreatic Ductal Adenocarcinoma Progression. Co-author DOI 10.1096/fj.202402903r↗
  3. BANCR positively regulates the HIF-1α/VEGF-C/VEGFR-3 pathway in a hypoxic microenvironment to promote lymphangiogenesis in pancreatic cancer cells. Co-author DOI 10.3892/ol.2022.13542↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yangyang Zheng · 2 shared papers, 2025 · strength 0.51
  2. Jinghai Song · 2 shared papers, 2025 · strength 0.51
  3. Jingyong Xu · 2 shared papers, 2025 · strength 0.51
  4. Shaolong Hao · 1 shared paper, 2022 · strength 0.16
  5. Yuchuan Ding · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.